Le Lézard
Classified in: Health, Business
Subjects: ERN, CCA, FVT, MAT

Abacus Health Products Announces Release Date, Conference Call and Webcast Details for 2019 First Quarter Financial Results


WOONSOCKET, RI, May 21, 2019 /CNW/ - Abacus Health Products, Inc. (CSE: ABCS) ("Abacus" or the "Company") will release its 2019 first quarter financial results on Thursday, May 30, 2019, after market close. Management will host a conference call the following day, Friday, May 31, 2019, at 10:00 AM Eastern Time to review the financial results.

Abacus Health Products, Inc. (CNW Group/Abacus Health Products)

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 1589844. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until June 7, 2019. To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 1589844.

A live audio webcast of the conference call will be available at: https://event.on24.com/wcc/r/1987807/2997221656884D343FD84AFA94B2E9D9

Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. An archived replay of the webcast will be available for 90 days by clicking the link above.

About Abacus Health Products, Inc.

Abacus is a company engaged in the development and commercialization of over-the-counter (OTC) registered topical medications with active pharmaceutical ingredients and which contain organic and natural ingredients, including a cannabinoid-rich hemp extract containing CBD from Cannabis sativa L plant. Abacus' products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending technologies developed by Abacus. Abacus' formulations combine advanced science with organic and natural ingredients to provide safe relief. Abacus currently offers two lines of products: (i) CBD CLINICtm, marketed to the professional practitioner market, and (ii) CBDMEDICtm, marketed to the consumer market. Abacus' products are offered across the United States and are produced by a contract manufacturer in a cGMP compliant and audited manufacturing facility.

To learn more about Abacus, visit www.abacushp.com

SOURCE Abacus Health Products


These press releases may also interest you

at 23:03
The report titled "Anti-Adhesion Products Market by Product Type (Natural Adhesion Barriers, Synthetic Adhesion Barriers), Product Form (Film Formulation, Gel Formulation, Liquid Formulation), Application, End-User - Global Forecast 2024-2030" is now...

at 22:29
Product: Meat and vegetable products Issue: Food - Microbial Contamination - Listeria Distribution:British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 22:03
The report titled "Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global...

at 21:30
Greenbrook TMS Inc. ("Greenbrook" or the "Company") today announced its fiscal year ended December 31, 2023 ("Fiscal 2023") operational and financial results. All values in this news release are in United States dollars, unless otherwise stated....

at 20:25
AIDS Healthcare Foundation applauds the government of Colombia for issuing a compulsory license on HIV drug dolutegravir, which will allow the country to access affordable generic versions of the treatment as an alternative to the costly branded...

at 20:12
BCACC is pleased to announce that its Deputy Registrar, Kathy Lauriente, has been honoured with the Distinguished Service Award from Thompson Rivers University. The award recognizes stellar contributions to the University, community, and the public...



News published on and distributed by: